부산대학교 도서관

Lin YY; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Breuer K; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Weichenhan D; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Lafrenz P; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Sarnataro A; Department of Oncology, KU Leuven, 3000 Leuven, Belgium.; Wilk A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Chepeleva M; Multiomics Data Science Research Group, Department of Cancer Research, Luxembourg Institute of Health, 1445 Strassen, Luxembourg.; Mücke O; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Schönung M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; Petermann F; NGS Core Facility, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Kensche PR; Omics-IT and Data Management Core Facility (ODCF), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Weiser L; Omics-IT and Data Management Core Facility (ODCF), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Thommen F; Omics-IT and Data Management Core Facility (ODCF), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Giacomelli G; Berlin Institute of Health, University Hospital Charité, 10178 Berlin, Germany.; Nordstroem K; Department of EpiGenetics, Saarland University, 66123 Saarbrücken, Germany.; Gonzalez-Avalos E; Division of Signaling and Gene Expression, La Jolla Institute for Immunology, La Jolla, CA 92037, United States.; Merkel A; Bioinformatics Development and Statistical Genomics, Center for Genomic Regulation (CRG), Centro Nacional de Análisis Genómico (CNAG), 08028 Barcelona, Spain.; Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Catalonia, Spain.; Kretzmer H; LIFE-Leipzig Research Center for Civilization Diseases, University Leipzig, 04103 Leipzig, Germany.; Max-Planck Institute for Molecular Genetics, 14195 Berlin, Germany.; Fischer J; Department for Computer Vision and Machine Learning, Max Planck Institute for Informatics, 66123 Saarbrücken, Germany.; Krämer S; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Biomedical Informatics, Data Mining and Data Analytics, Faculty of Applied Computer Science and Medical Faculty, University of Augsburg,86159 Augsburg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.; Iskar M; Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Wolf S; NGS Core Facility, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Buchhalter I; Omics-IT and Data Management Core Facility (ODCF), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Esteller M; Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Catalonia, Spain.; Institucio Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Catalonia, Spain.; Centro de Investigación Biomedica en Red Cancer (CIBERONC), 28029 Madrid, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), 08036 Barcelona, Catalonia, Spain.; Lawerenz C; Berlin Institute of Health, University Hospital Charité, 10178 Berlin, Germany.; Twardziok S; Berlin Institute of Health, University Hospital Charité, 10178 Berlin, Germany.; Zapatka M; Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Hovestadt V; Broad Institute of MIT and Harvard, Cambridge, MA 02142, United States.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, United States.; Schlesner M; Biomedical Informatics, Data Mining and Data Analytics, Faculty of Applied Computer Science and Medical Faculty, University of Augsburg,86159 Augsburg, Germany.; Schulz MH; Institute for Computational Genomic Medicine, Goethe University,60590 Frankfurt-am-Main, Germany.; German Center for Cardiovascular Research, 60590 Frankfurt-am-Mein, Germany.; Hoffmann S; LIFE-Leipzig Research Center for Civilization Diseases, University Leipzig, 04103 Leipzig, Germany.; Computational Biology Group, Leibniz Institute on Aging-Fritz Lipmann Institute and Friedrich Schiller, University of Jena, 07745 Jena, Germany.; Gerhauser C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Walter J; Department of EpiGenetics, Saarland University, 66123 Saarbrücken, Germany.; Hartmann M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; Faculty of Medicine, Otto-von-Guericke-University,39120 Magdeburg, Germany.; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.; Assenov Y; Department of Mathematics and Technology, RheinAhrCampus Remagen, University of Applied Sciences Koblenz, 53424 Remagen, Germany.; Bock C; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.; Institute of Artificial Intelligence, Center for Medical Data Science, Medical University of Vienna,1090 Vienna, Austria.; Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Toth R; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Multiomics Data Science Research Group, Department of Cancer Research, Luxembourg Institute of Health, 1445 Strassen, Luxembourg.; Lutsik P; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Oncology, KU Leuven, 3000 Leuven, Belgium.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN: 1362-4962 (Electronic) Linking ISSN: 03051048 NLM ISO Abbreviation: Nucleic Acids Res Subsets: MEDLINE

Hübschmann D; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Innovation and Service Unit for Bioinformatics and Precision Medicine, DKFZ, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany. d.huebschmann@dkfz-heidelberg.de.; Kreutzfeldt S; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Roth B; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Glocker K; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Medical Genetics Center, Munich, Germany.; Schoop J; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Oeser L; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Hausmann S; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Koch C; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Uhrig S; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Hüllein J; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Hutter B; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Fröhlich M; Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, Heidelberg, Germany.; Heilig CE; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Teleanu MV; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Lipka DB; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Kerle IA; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany.; Baude-Müller A; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Beck K; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Heining C; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany.; Glimm H; Department of Translational Medical Oncology, NCT, NCT/University Cancer Center (NCT/UCC) Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; DKTK, Partner Site Dresden, Dresden, Germany.; Ückert F; Institute for Applied Medical Informatics, Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Knurr A; Secondary Use of Data in Oncology Group, Clinical Trial Office, DKFZ, Heidelberg, Germany.; Fröhling S; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Horak P; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany. peter.horak@nct-heidelberg.de.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany. peter.horak@nct-heidelberg.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Hartmann M; German Cancer Research Center, DKFZ, Heidelberg, Germany.; Schönung M; German Cancer Research Center, Heidelberg, Germany.; Rajak J; University Medical Center Freiburg, Freiburg, Germany.; Maurer V; German Cancer Research Center, DKFZ, Heidelberg, Germany.; Hai L; German Cancer Research Center, Germany.; Bauer K; German Cancer Research Center, Heidelberg, Germany.; Hakobyan M; German Cancer Research Center, Heidelberg, Germany.; Stäble S; German Cancer Research Center, Heidelberg, 69120, Germany.; Langstein J; AstraZeneca, Toronto, Canada, United States.; Jardine L; Newcastle University, United Kingdom.; Roelz R; University of Freiburg, Freiburg, Germany.; Bohler S; University Medical Center Freiburg, Freiburg, Germany.; Khabirova E; Wellcome Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.; Maag AH; University Hospital Ulm, Ulm, Germany.; Vonficht D; German Cancer Research Center, Berlin, Germany.; Lebrecht D; University Medical Center Freiburg, Freiburg, Germany.; Bernt KM; Children's Hospital of Philadelphia, Philadelphia, PA, United States.; Tan K; Children's Hospital of Philadelphia, Philadelphia, PA, United States.; Chen C; Children's Hospital of Philadelphia, United States.; Alikarami F; Children's Hospital of Philadelphia, Philadelphia, United States.; Meyer J; UCSF Benioff Children's Hospital, San Francisco, CA, United States.; Wang J; University of Freiburg, China.; Boch T; Medizinische Fakultät Mannheim, Mannheim, Germany.; Flore V; German Cancer Research Center, Germany.; Lutsik P; KU Leuven, Leuven, Belgium.; Milsom MD; German Cancer Research Center, Heidelberg, Germany.; Raffel S; University Hospital Heidelberg, Heidelberg, Germany.; Buske C; University Hospital Ulm, Ulm, Germany.; Haas S; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Haniffa M; Wellcome Sanger Institute, Cambridge, United Kingdom.; Mallm JP; German Cancer Research Center, Heidelberg, Germany.; Behjati S; Wellcome Trust Sanger Institute, Cambridgeshire, United Kingdom.; Bonder MJ; German Cancer Research Center, Germany.; Frohling S; National Center for Tumor Diseases, Heidelberg, Germany.; Stieglitz E; University of California, San Francisco, San Francisco, California, United States.; Niemeyer CM; University of Freiburg, Freiburg, Germany.; Hey J; German Cancer Research Center, Heidelberg, Baden-Württemberg, Germany.; Flotho C; University Medical Center Freiburg, Freiburg, Germany.; Plass C; German Cancer Research Center, Heidelberg, Germany.; Erlacher M; University Medical Center Freiburg, Freiburg, Germany.; Schlesner M; University of Augsburg, Augsburg, Germany.; Lipka DB; German Cancer Research Center, Heidelberg, Germany.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

Weichenhan, Dieter; Riedel, Anna; Sollier, Etienne; Toprak, Umut H; Hey, Joschka; Breuer, Kersten Henrik; Wierzbinska, Justyna Anna; Touzart, Aurore; Lutsik, Pavlo; Bähr, Marion; Östlund, Anders; Nilsson, Tina; Jacobsson, Susanna; Waraky, Ahmed; Behrens, Yvonne Lisa; Göhring, Gudrun; Schlegelberger, Brigitte; Steinek, Clemens; Harz, Hartmann; Leonhardt, Heinrich; Dolnik, Anna; Reinhardt, Dirk; Bullinger, Lars; Palmqvist, Lars, 1965; Lipka, Daniel B; Plass, Christoph

Blood Advances. 8(19):5100-5111

Ghanjati F; Department of Pediatric Hematology and Oncology, Children's Hospital, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. foued.ghanjati@uniklinik-freiburg.de.; Heck A; Department of Pediatric Hematology and Oncology, Children's Hospital, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Lebrecht D; Department of Pediatric Hematology and Oncology, Children's Hospital, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Nöllke P; Department of Pediatric Hematology and Oncology, Children's Hospital, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Andresen F; Department of Pediatric Hematology and Oncology, Children's Hospital, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Rotari N; Department of Pediatric Hematology and Oncology, Children's Hospital, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Schoof M; Department of Pediatric Hematology and Oncology, Children's Hospital, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Schönung M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between, DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between, DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), DKFZ, Core Center, Heidelberg, Germany.; Dworzak M; St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Anna Children's Cancer Research Institute (CCRI), Medical University of Vienna, and St., Vienna, Austria.; De Moerloose B; Department of Paediatric Haematology-Oncology, Ghent University Hospital, Ghent, Belgium.; Sukova M; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.; Hasle H; Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark.; Jahnukainen K; Division of Hematology-Oncology and SCT Children´S Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Malone A; Pediatric Haematology, Our Lady's Children's Hospital, Dublin, Ireland.; Masetti R; Pediatric Oncology and Haematology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.; Buechner J; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.; Ussowicz M; Department of Pediatric Hematology and Oncology, BMT Unit CIC 817, Wroclaw Medical University, Wrocław, Poland.; Catala A; Department of Hematology and Oncology, Hospital Sant Joan de Deu, Barcelona, Spain.; Turkiewicz D; Department of Pediatrics, Section of Pediatric Oncology, Hematology, Immunology and Nephrology, Skåne University Hospital, Lund, Sweden.; de Haas V; Dutch Childhood Oncology Group, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Schmugge M; Department of Hematology and Oncology, University Children's Hospital, Zurich, Switzerland.; Erlacher M; Department of Pediatric Hematology and Oncology, Children's Hospital, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, a partnership between, DKFZ and University Medical Center, Freiburg, Germany.; Niemeyer CM; Department of Pediatric Hematology and Oncology, Children's Hospital, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, a partnership between, DKFZ and University Medical Center, Freiburg, Germany.; Flotho C; Department of Pediatric Hematology and Oncology, Children's Hospital, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. christian.flotho@uniklinik-freiburg.de.; German Cancer Consortium (DKTK), Partner Site Freiburg, a partnership between, DKFZ and University Medical Center, Freiburg, Germany. christian.flotho@uniklinik-freiburg.de.

Publisher: Biomed Central Country of Publication: Germany NLM ID: 101516977 Publication Model: Electronic Cited Medium: Internet ISSN: 1868-7083 (Electronic) Linking ISSN: 18687075 NLM ISO Abbreviation: Clin Epigenetics Subsets: MEDLINE

Schönung M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Rathmann S; Department of Pediatric Hematology and Oncology, Faculty of Medicine, Children's Hospital, Medical Center, University of Freiburg, Freiburg, Germany.; Ramamoorthy S; Department of Pediatric Hematology and Oncology, Faculty of Medicine, Children's Hospital, Medical Center, University of Freiburg, Freiburg, Germany.; Faculty of Medicine, Institute of Medical Bioinformatics and Systems Medicine, Medical Center, University of Freiburg, Freiburg, Germany.; Lebrecht D; Department of Pediatric Hematology and Oncology, Faculty of Medicine, Children's Hospital, Medical Center, University of Freiburg, Freiburg, Germany.; Klingebiel T; Department of Pediatrics, Frankfurt University Hospital, Frankfurt, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.; Locatelli F; Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesu, Rome, Italy.; Department of Pediatrics, Catholic University of the Sacred Heart, Rome, Italy.; Nysom K; Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.; Rossig C; Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.; Starý J; Department of Paediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.; Zecca M; Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Patturajan M; Bristol Myers Squibb, Summit, New Jersey, USA.; Erlacher M; Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.; Strahm B; Department of Pediatric Hematology and Oncology, Faculty of Medicine, Children's Hospital, Medical Center, University of Freiburg, Freiburg, Germany.; Niemeyer CM; Department of Pediatric Hematology and Oncology, Faculty of Medicine, Children's Hospital, Medical Center, University of Freiburg, Freiburg, Germany.; Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany.; Flotho C; Department of Pediatric Hematology and Oncology, Faculty of Medicine, Children's Hospital, Medical Center, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, a Partnership between DKFZ and University Medical Center Freiburg, Freiburg, Germany.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Kelekçi S; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; Faculty of Biosciences, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.; Kelly K; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; Faculty of Biosciences, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.; Goyal A; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; Cancer-related Advanced Research and Education, TCG CREST, Kolkata, India.; Wehrwein N; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; Molecular Biosciences/Cancer Biology Programme, University of Heidelberg and German Cancer Research Centre (DKFZ), Heidelberg, Germany.; Riedel A; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; Faculty of Biosciences, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.; Weichenhan D; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; Scherer M; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; Michels BE; Division of Molecular Genome Analysis, German Cancer Research Center, Heidelberg, Germany.; Körner C; Division of Molecular Genome Analysis, German Cancer Research Center, Heidelberg, Germany.; Orzella I; Department of Pharmacy, Universita degli studi di Camerino, Camerino, Italy.; Hakobyan M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, DKFZ; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Bähr M; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; Everatt E; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; Faculty of Biosciences, Ruprecht Karl University of Heidelberg, Heidelberg, Germany.; Dunford J; Botnar Research Centre, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.; Oxford Translational Myeloma Centre, University of Oxford, Oxford, UK.; Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, DKFZ; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Lutsik P; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany.; Department of Oncology, Catholic University Leuven, Leuven, Belgium.; Oppermann U; Botnar Research Centre, Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.; Oxford Translational Myeloma Centre, University of Oxford, Oxford, UK.; Plass C; Division of Cancer Epigenomics, German Cancer Research Center, Heidelberg, Germany. c.plass@dkfz.de.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process

Haage, Tobias Ronny; Charakopoulos, Emmanouil; Bhuria, Vikas; Baldauf, Conny K; Korthals, Mark; Handschuh, Juliane; Müller, Peter; Li, Juan; Harit, Kunjan; Nishanth, Gopala; Frey, Stephanie; Böttcher, Martin; Fischer, Klaus-Dieter; Dudeck, Jan; Dudeck, Anne; Lipka, Daniel B; Schraven, Burkhart; Green, Anthony R; Müller, Andreas J; Mougiakakos, Dimitrios; Fischer, Thomas

J Hematol Oncol
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-23 (2024)

Mohanty S; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY.; Charles Cano F; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Gabdoulline R; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Lai CK; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Othman B; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Sudarsanam H; Institute of Transfusion Medicine, University Hospital Leipzig, Leipzig, Germany.; Eder T; Centre for Biological Sciences, University of Veterinary Medicine Vienna, Vienna, Austria.; Grebien F; Centre for Biological Sciences, University of Veterinary Medicine Vienna, Vienna, Austria.; St. Anna Children's Cancer Research Institute, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Lipka DB; Section of Translational Cancer Epigenomics, Department of Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany.; Henschler R; Institute of Transfusion Medicine, University Hospital Leipzig, Leipzig, Germany.; Heuser M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Department of Internal Medicine IV, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Baldauf CK; Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Healthcampus Immunology, Inflammation and Infectiology (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Fahldieck C; Department of Hematology, Oncology and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Angenstein A; Department of Hematology, Oncology and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Weinert S; University Clinic for Cardiology and Angiology, Otto-von-Guericke University, Medical Faculty, Magdeburg, Germany.; Hakobyan M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between, DKFZ and Heidelberg University Hospital , Heidelberg, Germany.; Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between, DKFZ and Heidelberg University Hospital , Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Haage TR; Department of Hematology, Oncology and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Bhuria V; Healthcampus Immunology, Inflammation and Infectiology (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Department of Hematology, Oncology and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Böttcher M; Healthcampus Immunology, Inflammation and Infectiology (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Department of Hematology, Oncology and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Mougiakakos D; Healthcampus Immunology, Inflammation and Infectiology (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Department of Hematology, Oncology and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Center for Health and Medical Prevention - CHAMP, Otto-von-Guericke University, Magdeburg, Germany.; Schraven B; Institute for Molecular and Clinical Immunology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Healthcampus Immunology, Inflammation and Infectiology (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany.; Center for Health and Medical Prevention - CHAMP, Otto-von-Guericke University, Magdeburg, Germany.; Fischer T; Healthcampus Immunology, Inflammation and Infectiology (GC-I3), Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany. thomas.fischer@med.ovgu.de.; Department of Hematology, Oncology and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany. thomas.fischer@med.ovgu.de.; Center for Health and Medical Prevention - CHAMP, Otto-von-Guericke University, Magdeburg, Germany. thomas.fischer@med.ovgu.de.

Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X (Electronic) Linking ISSN: 1478811X NLM ISO Abbreviation: Cell Commun Signal Subsets: MEDLINE

Sollier E; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Riedel A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Toprak UH; Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Wierzbinska JA; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Weichenhan D; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schmid JP; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; German Cancer Consortium (DKTK), Partner site Munich, A partnership between DKFZ and University Hospital LMU Munich, Munich, Germany.; Hakobyan M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, A partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Touzart A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Université de Paris Cité, Institut Necker Enfants-Malades (INEM), Institut National de la Santé et de la Recherche Médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.; Jahn E; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.; Vick B; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; German Cancer Consortium (DKTK), Partner site Munich, A partnership between DKFZ and University Hospital LMU Munich, Munich, Germany.; Brown-Burke F; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Kelly K; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Kelekçi S; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Pejkovska A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Goyal A; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bähr M; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Breuer K; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Chen MM; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Llamazares-Prada M; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hartmann M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, A partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Schönung M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, A partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Correia N; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Trumpp A; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Abdullah Y; Division Systems Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Klingmüller U; Division Systems Biology of Signal Transduction, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Mughal SS; Division Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Brors B; National Center for Tumor Diseases (NCT), NCT Heidelberg, A partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Medical Faculty and Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Westermann F; Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Ulrich E; German Cancer Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Autry RJ; German Cancer Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schlesner M; Biomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, Germany.; Vosberg S; German Cancer Consortium (DKTK), Partner site Munich, A partnership between DKFZ and University Hospital LMU Munich, Munich, Germany.; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Herold T; German Cancer Consortium (DKTK), Partner site Munich, A partnership between DKFZ and University Hospital LMU Munich, Munich, Germany.; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Greif PA; German Cancer Consortium (DKTK), Partner site Munich, A partnership between DKFZ and University Hospital LMU Munich, Munich, Germany.; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Pfeifer D; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.; Lübbert M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.; Fischer T; Department of Hematology and Oncology, Medical Center, Otto-von-Guericke University, Magdeburg, Germany.; Heidel FH; Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany.; Leibniz Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany.; Gebhard C; Interventional Immunology, Leibniz Institute for Immunotherapy, Regensburg, Germany.; Walter W; MLL Munich Leukemia Laboratory, Munich, Germany.; Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany.; Eisfeld AK; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Mrózek K; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Nicolet D; Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité, Universitätsmedizin Berlin, Berlin, Germany.; Smeenk L; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Erpelinck-Verschueren C; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Mulet-Lazaro R; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Delwel R; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Ernst A; German Cancer Consortium (DKTK), Heidelberg, Germany.; Group Genome Instability in Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Scherer M; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Lutsik P; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Oncology, KU Leuven, Leuven, Belgium.; Jeremias I; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Munich, German Research Center for Environmental Health, Munich, Germany.; German Cancer Consortium (DKTK), Partner site Munich, A partnership between DKFZ and University Hospital LMU Munich, Munich, Germany.; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany.; Döhner K; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.; Döhner H; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.; Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, A partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Faculty of Medicine, Otto-von-Guericke-University, Magdeburg, Germany.; Plass C; Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

Möhrmann L; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, USA; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany. Electronic address: lino.moehrmann@nct-dresden.de.; Rostock L; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany.; Werner M; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Oleś M; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Arnold JS; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; Paramasivam N; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Jöhrens K; Department of Pathology, University Hospital Carl Gustav Carus, Dresden, Germany.; Rupp L; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Schmitz M; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany.; Richter D; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany.; Uhrig S; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Fröhlich M; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Hutter B; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Hüllein J; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Jahn A; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; Arlt M; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; Möhrmann EE; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Hanf D; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Gieldon L; Institute of Medical Genetics, Carl von Ossietzky University, Oldenburg, Germany.; Kreutzfeldt S; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany.; Heilig CE; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany.; Teleanu MV; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany.; Lipka DB; Section Translational Cancer Epigenomics, Department of Translational Medical Oncology, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Beck K; Institute of Medical Genetics, Carl von Ossietzky University, Oldenburg, Germany.; Baude-Müller A; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany; Section Translational Cancer Epigenomics, Department of Translational Medical Oncology, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Mock A; Institute of Pathology, Ludwig-Maximilians-Universität München (LMU), Munich, Germany.; Jelas I; Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Rieke DT; Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Wiesweg M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.; Brandts C; Department of Medicine, Hematology/Oncology, University Hospital, Goethe University, Frankfurt, Germany; University Cancer Center Frankfurt (UCT), University Hospital, Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.; Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, and Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.; Illert AL; Department of Internal Medicine I, Division of Hematology, Oncology and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg im Breisgau, Germany; Klinik und Poliklinik für Innere Medizin III, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.; Desuki A; University Cancer Center and Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany; TRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany; DKTK, partner site Frankfurt/Mainz, a partnership between DKFZ and University Medical Center Mainz, Mainz, Germany.; Kindler T; University Cancer Center and Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany; TRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany; DKTK, partner site Frankfurt/Mainz, a partnership between DKFZ and University Medical Center Mainz, Mainz, Germany.; Krackhardt AM; Klinik und Poliklinik für Innere Medizin III, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.; Westphalen CB; Department of Internal Medicine III, University Hospital, LMU Munich and Comprehensive Cancer Center, Munich, Germany.; Christopoulos P; Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, and NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center, member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Apostolidis L; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.; Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Allgäuer M; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Neumann O; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Kerle IA; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Horak P; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany.; Heining C; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.; Grosch H; Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, and NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center, member of the German Center for Lung Research (DZL), Heidelberg, Germany.; Schröck E; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; ERN GENTURIS, Hereditary Cancer Syndrome Center Dresden, Dresden, Germany; Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.; Hübschmann D; Computational Oncology Group (CO), Molecular Precision Oncology Program (MPOP), German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany; Innovation and Service Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; Fröhling S; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.; Glimm H; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany; Translational Functional Cancer Genomics, DKFZ Heidelberg, Heidelberg, Germany. Electronic address: hanno.glimm@nct-dresden.de.

Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med Subsets: MEDLINE

Cabezas-Wallscheid, Nina; Klimmeck, Daniel; Hansson, Jenny; Lipka, Daniel B; Reyes, Alejandro; Wang, Qi; Weichenhan, Dieter; Lier, Amelie; von Paleske, Lisa; Renders, Simon; Wünsche, Peer; Zeisberger, Petra; Brocks, David; Gu, Lei; Herrmann, Carl; Haas, Simon; Essers, Marieke A G; Brors, Benedikt; Eils, Roland; Huber, Wolfgang; Milsom, Michael D; Plass, Christoph; Krijgsveld, Jeroen; Trumpp, Andreas

Cell Stem Cell. 15(4):507-22

Schöpf J; Division of Applied Functional Genomics, German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Uhrig S; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg, and DKFZ, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Heilig CE; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Lee KS; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Walther T; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Carazzato A; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Dobberkau AM; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Weichenhan D; Division of Cancer Epigenomics, DKFZ, Heidelberg, Germany.; Plass C; Division of Cancer Epigenomics, DKFZ, Heidelberg, Germany.; Hartmann M; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Diwan GD; Bioquant, Heidelberg University, Heidelberg, Germany.; Heidelberg University Biochemistry Center (BZH), Heidelberg, Germany.; Carrero ZI; Department for Translational Medical Oncology, NCT, NCT/UCC Dresden, a Partnership Between DKFZ, Heidelberg Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; Ball CR; Department for Translational Medical Oncology, NCT, NCT/UCC Dresden, a Partnership Between DKFZ, Heidelberg Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD, Dresden, Germany.; Faculty of Biology, TUD Dresden University of Technology, Dresden, Germany.; Hohl T; Division of Applied Functional Genomics, German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Kindler T; University Cancer Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.; Department of Hematology, Medical Oncology and Pneumology, University Medical Center, Mainz, Germany.; German Cancer Consortium (DKTK), Mainz, Germany.; Rudolph-Hähnel P; University Cancer Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.; Department of Hematology, Medical Oncology and Pneumology, University Medical Center, Mainz, Germany.; German Cancer Consortium (DKTK), Mainz, Germany.; Helm D; Proteomics Core Facility, DKFZ, Heidelberg, Germany.; Schneider M; Proteomics Core Facility, DKFZ, Heidelberg, Germany.; Nilsson A; Pediatric Oncology and Coagulation, Karolinska University Hospital, Stockholm, Sweden.; Øra I; Pediatric Oncology and Hematology, Skåne University Hospital, Lund University, Lund, Sweden.; Imle R; Soft-Tissue Sarcoma Junior Research Group, DKFZ, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ) and NCT Heidelberg, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Banito A; Soft-Tissue Sarcoma Junior Research Group, DKFZ, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ) and NCT Heidelberg, Heidelberg, Germany.; Russell RB; Bioquant, Heidelberg University, Heidelberg, Germany.; Heidelberg University Biochemistry Center (BZH), Heidelberg, Germany.; Jones BC; German Cancer Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ) and NCT Heidelberg, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Lipka DB; Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany.; Glimm H; Department for Translational Medical Oncology, NCT, NCT/UCC Dresden, a Partnership Between DKFZ, Heidelberg Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; German Cancer Consortium (DKTK), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD, Dresden, Germany.; Translational Functional Cancer Genomics, DKFZ, Heidelberg, Germany.; Hübschmann D; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg, and DKFZ, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.; Hartmann W; Gerhard Domagk Institute of Pathology, University Hospital Münster, Münster, Germany.; Fröhling S; Division of Translational Medical Oncology, DKFZ, and NCT Heidelberg, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.; Scholl C; Division of Applied Functional Genomics, German Cancer Research Center (DKFZ), and National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany. claudia.scholl@nct-heidelberg.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Teleanu MV; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Schneider A; School of Life Sciences, Technical University Munich, 85354 Freising, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, 80336 Munich, Germany.; Ball CR; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT)/University Cancer Center Dresden, a Partnership Between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden University of Technology (TUD), and Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden University of Technology (TUD), 01069 Dresden, Germany.; Faculty of Biology, Dresden University of Technology (TUD), 01217 Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany.; Leber MF; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; Department of Medical Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Stange C; School of Life Sciences, Technical University Munich, 85354 Freising, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, 80336 Munich, Germany.; Krieghoff-Henning E; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Personalized Oncology, DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Department of Personalized Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Beck K; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Heilig CE; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Kreutzfeldt S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Kuster B; School of Life Sciences, Technical University Munich, 85354 Freising, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, 80336 Munich, Germany.; Lipka DB; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, 69120 Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, 69120 Heidelberg, Germany.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X (Electronic) Linking ISSN: 2218273X NLM ISO Abbreviation: Biomolecules Subsets: MEDLINE

Daskalakis, Michael ; Brocks, David ; Schmidt, Christopher ; Li, Daofeng ; Li, Jing ; Jang, Hyo S. ; Zhang, Bo ; Lipka, Daniel B ; Schott, Johanna ; Bierhoff, Holger ; Assenov, Yassen ; Helf, Monika ; Ressnerova, Alzbeta ; Lindroth, Anders ; Haas, Simon ; Essers, Marieke A.G. ; Imbusch, Charles D. ; Brors, Benedikt ; Oehme, Ina ; Witt, Olaf ; Lübbert, Michael ; Stoecklin, Georg ; Gerhäuser, Clarissa ; Oakes, Christopher C ; Wang, Ting ; Plass, Christoph

In Blood 2 December 2016 128(22):3931-3931

Bogeska, Ruzhica ; Kaschutnig, Paul ; Paffenholz, Stella ; Maassen, Julia ; Mallm, Jan-Philipp ; Wertek, Felix ; Walter, Dagmar ; Sandra, Blaszkiewicz ; Holland-Letz, Tim ; Asada, Noboru ; Gräsel, Julius ; Stäble, Sina ; Block, Milena ; Gizlenci, Özge ; Prendergast, Áine M. ; Haas, Simon ; Lipka, Daniel B ; Rippe, Karsten ; Brors, Benedikt ; Frenette, Paul S. ; Essers, Marieke A.G. ; Milsom, Michael D.

In Blood 2 December 2016 128(22):1472-1472

Sill, Martin; Plass, Christoph; Pfister, Stefan M; Lipka, Daniel B

Human Molecular Genetics; 10/1/2020, Vol. 29 Issue R2, pR205-R213, 9p

Mock A; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Pathology, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany.; Teleanu MV; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology, Oncology and Rheumatology, Heidelberg Unversity Hospital, Heidelberg, Germany.; Kreutzfeldt S; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heilig CE; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hüllein J; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Möhrmann L; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases/University Cancer Center (NCT/UCC) Dresden, Dresden, Germany.; DKFZ, Heidelberg, Germany.; Jahn A; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, Technische Universität Dresden and Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; Hanf D; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases/University Cancer Center (NCT/UCC) Dresden, Dresden, Germany.; DKFZ, Heidelberg, Germany.; Kerle IA; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases/University Cancer Center (NCT/UCC) Dresden, Dresden, Germany.; DKFZ, Heidelberg, Germany.; Singh HM; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.; Hutter B; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Uhrig S; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Fröhlich M; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Neumann O; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Hartig A; Institute of Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Brückmann S; Institute of Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Hirsch S; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany.; Grund K; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany.; Dikow N; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany.; Lipka DB; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Translational Cancer Epigenomics, Division of Translational Medical Oncology, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Renner M; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bhatti IA; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.; Apostolidis L; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.; Schlenk RF; Department of Hematology, Oncology and Rheumatology, Heidelberg Unversity Hospital, Heidelberg, Germany.; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.; NCT Trial Center, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Schaaf CP; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany.; Stenzinger A; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Schröck E; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Institute for Clinical Genetics, University Hospital Carl Gustav Carus, Technische Universität Dresden and Hereditary Cancer Syndrome Center Dresden, Dresden, Germany.; Hübschmann D; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.; Heining C; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases/University Cancer Center (NCT/UCC) Dresden, Dresden, Germany.; DKFZ, Heidelberg, Germany.; Horak P; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Glimm H; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.; Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases/University Cancer Center (NCT/UCC) Dresden, Dresden, Germany.; DKFZ, Heidelberg, Germany.; Fröhling S; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany. stefan.froehling@nct-heidelberg.de.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Oakes, Christopher C. ; Seifert, Marc ; Assenov, Yassen ; Gu, Lei ; Przekopowitz, Martina ; Ruppert, Amy S. ; Wang, Qi ; Imbusch, Charles ; Serva, Andrius ; Koser, Sandra ; Brocks, David ; Lipka, Daniel B ; Bogatyrova, Olga ; Brors, Benedikt ; Weichenhan, Dieter ; Rassenti, Laura Z. ; Kipps, Thomas J. ; Mertens, Daniel ; Zapatka, Marc ; Lichter, Peter ; Döhner, Hartmut ; Kueppers, Ralf ; Zenz, Thorsten ; Stilgenbauer, Stephan ; Byrd, John C ; Plass, Christoph

In Blood 3 December 2015 126(23):2436-2436